We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.8B
AUM Growth
+$2.95B
Cap. Flow
+$1.1B
Cap. Flow %
4.63%
Top 10 Hldgs %
44.66%
Holding
165
New
18
Increased
38
Reduced
31
Closed
20

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.14B
2
AMZN icon
Amazon
AMZN
+$601M
3
AON icon
Aon
AON
+$226M
4
TMO icon
Thermo Fisher Scientific
TMO
+$145M
5
AZEK
The AZEK Co
AZEK
+$100M

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$816M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$403M
3
EXEL icon
Exelixis
EXEL
+$260M
4
MSFT icon
Microsoft
MSFT
+$234M
5
INTU icon
Intuit
INTU
+$205M

Sector Composition

Rank Sector Weight
1 Healthcare 32.61%
2 Technology 13.02%
3 Financials 8.98%
4 Communication Services 7.2%
5 Industrials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
26
Charles Schwab
SCHW
$187B
$361M 1.52%
3,959,057
+126,200
+3% +$10.6M
ANSS
27
DELISTED
Ansys
ANSS
$350M 1.47%
997,128
+49,128
+5% +$16.1M
PTGX icon
28
Protagonist Therapeutics
PTGX
$9.46B
$341M 1.43%
6,172,006
+65,000
+1% +$3.12M
BBIO icon
29
BridgeBio Pharma
BBIO
$16.2B
$341M 1.43%
7,900,000
+2,169,000
+38% +$78.9M
NYT icon
30
New York Times
NYT
$10.4B
$314M 1.32%
5,609,546
-3,322,567
-37% -$176M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.36T
$313M 1.31%
1,761,840
+95,800
+6% +$15.8M
ADI icon
32
Analog Devices
ADI
$184B
$303M 1.27%
1,272,200
-54,800
-4% -$11.4M
CBRE icon
33
CBRE Group
CBRE
$42.7B
$296M 1.24%
2,113,138
-382,562
-15% -$48.4M
WAB icon
34
Wabtec
WAB
$49.9B
$274M 1.15%
1,308,198
-299,900
-19% -$57.7M
MCK icon
35
McKesson
MCK
$102B
$231M 0.97%
314,600
-237,900
-43% -$168M
WWD icon
36
Woodward
WWD
$21.6B
$224M 0.94%
914,673
-505,027
-36% -$103M
AGIO icon
37
Agios Pharmaceuticals
AGIO
$1.91B
$192M 0.81%
5,767,466
+67,000
+1% +$2.03M
VRNA
38
DELISTED
Verona Pharma
VRNA
$171M 0.72%
1,810,000
+725,011
+67% +$53.7M
AZEK
39
DELISTED
The AZEK Co
AZEK
$171M 0.72%
3,141,400
+2,001,400
+176% +$100M
BEAM icon
40
Beam Therapeutics
BEAM
$2.81B
$170M 0.72%
10,013,111
+85,000
+0.9% +$1.48M
K
41
DELISTED
Kellanova
K
$140M 0.59%
1,763,132
-1,556,868
-47% -$127M
CRNX icon
42
Crinetics Pharmaceuticals
CRNX
$8.9B
$134M 0.56%
4,646,098
+41,000
+0.9% +$1.27M
V icon
43
Visa
V
$692B
$110M 0.46%
308,810
-165,400
-35% -$57.7M
CHX
44
DELISTED
ChampionX
CHX
$105M 0.44%
4,245,000
+1,340,000
+46% +$33.7M
GEHC icon
45
GE HealthCare
GEHC
$31.8B
$97.9M 0.41%
1,322,000
+785,000
+146% +$54.6M
THC icon
46
Tenet Healthcare
THC
$20.7B
$93.1M 0.39%
+529,000
New +$79.6M
EHC icon
47
Encompass Health
EHC
$12.4B
$86.8M 0.36%
708,000
+89,000
+14% +$10.2M
MA icon
48
Mastercard
MA
$505B
$85.5M 0.36%
152,071
-49,300
-24% -$27.3M
CAH icon
49
Cardinal Health
CAH
$55.7B
$76.3M 0.32%
454,000
+181,000
+66% +$26.9M
EDU icon
50
New Oriental
EDU
$9.04B
$62.3M 0.26%
1,155,150
-150,000
-11% -$7.12M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Farallon Capital Management held 165 positions worth $23.8B, up 14% from $20.9B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Farallon Capital Management deployed $1.1B of net new capital in Q2 2025, opening 18 new positions and adding to 38 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 5,500,000 shares worth $3.4B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 38% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Exelixis, an estimated $260M trimmed.

  • Farallon Capital Management's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 5,500,000 shares worth $3.4B.
  • Farallon Capital Management added most to Aon in Q2 2025, an estimated $226M increase.
  • Farallon Capital Management's biggest Q2 2025 reduction was Exelixis, cutting an estimated $260M.
  • Farallon Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $816M.
  • Farallon Capital Management's ten largest holdings make up 45% of its $23.8B portfolio in Q2 2025.
  • Farallon Capital Management opened 18 new positions and closed 20 in Q2 2025.
  • Farallon Capital Management's portfolio value rose 14% quarter-over-quarter to $23.8B.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.